Norian Corp.

The pharmaceutical industry has been distressed by the government's efforts to hold individuals criminally liable for violations of the Food, Drug, and Cosmetic Act. So the case of two executives sent

Synthes execs sentenced to prison Three former executives from spinal fixation device maker Synthes Inc. and its former subsidiary Norian Corp. were sentenced to time in prison and a $100,000

The medical technology arena is home to a number of “game-changing” technologies that initially took the industry by storm only to see their meteoric rise followed by a precipitous fall. The drug-elut

A look at financing, M&A, and alliance activity April-June 2011 In this issue, we present another installment of our quarterly review of device/diagnostics dealmaking – for the second quarter of 2011.